Lubna Farhana

Lubna Farhana

Auto-generated profile, based on publicly available information

Lubna Farhana

Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
LFLubna Farhana
Lubna Farhana
FRFima Perdani Rahayu
Fima Perdani Rahayu
SSShofuro Sholihah
Shofuro Sholihah
WSWaleed Sweileh
Waleed Sweileh
RARizky Abdulah
Rizky Abdulah
SASofa Dewi Alfian
Sofa Dewi Alfian
Background: Managing chronic diseases often requires long-term treatment to prevent complications. However, the effectiveness of treatment is often reduced due to poor medication adherence. Poor medication adherence has been associated with 1.1 million hospital days in France and contributes to 200,000 premature deaths in Europe. As primary providers of pharmaceutical care, pharmacists have implemented various intervention strategies to address the problem. Therefore, this study aims to systematically examine the effectiveness of pharmacist-led interventions in improving medication adherence among patients with chronic diseases. Methods: Literature search was conducted using 2 databases (PubMed and EBSCO), focusing on RCTs published until October 2024. These RCTs analyzed the impact of pharmacist-led interventions on medication adherence in chronic diseases, such as hypertension, diabetes, dyslipidemia, asthma, cardiovascular disease, and COPD. Studies on multiple chronic, acute, or mental conditions were excluded. The Risk of Bias 2 tool (RoB2) was used to assess the quality of the studies. Results: Among 75 studies, a total of 26 were included, with the majority conducted in Europe (42%). In addition, 4 types of interventions were identified, including counseling (53.8%), tailored (26.9%), technology-based monitoring (3.85%), and multiple interventions (15.4%). A total of 18 studies (69.2%) demonstrated a significant association between pharmacist-led interventions and medication adherence. The majority measured adherence using self-reported questionnaires. Bias assessment results showed that 7 studies had low risk of bias, 10 had high risk, and 9 had some concerns. Conclusion: Pharmacist-led interventions, such as counseling, tailored, and multiple interventions, can improve medication adherence in chronic diseases. Although pharmacist-led interventions show promising potential, their effectiveness varies depending on the type of intervention and adherence measurements. Further studies are needed to focus on tailored interventions that address patient-specific barriers, ensuring higher efficiency in time, resources, and costs.

1 November 2025 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
SSShofuro Sholihah
Shofuro Sholihah
FRFima Perdani Rahayu
Fima Perdani Rahayu
LFLubna Farhana
Lubna Farhana
SASameer Alshehri
Sameer Alshehri
SASofa Dewi Alfian
Sofa Dewi Alfian
RARizky Abdulah
Rizky Abdulah
Background: Patients with multimorbidity tend to have multiple medications or polypharmacy to achieve optimal outcomes, which may result in non-adherence to medication. Medication non-adherence in this population is relatively higher than in patients with a single disease because of more complex medication regimens and greater adverse drug reactions. Providing interventions is an essential solution in changing patients’ behavior towards medication adherence among patients with multimorbidity. Pharmacists could help patients achieve optimal outcomes by optimizing medication use, including improving medication adherence. This scoping review aims to identify evidence of the effectiveness and characterize pharmacist-led interventions in improving medication adherence among patients with multimorbidity. Methods: A systematic search was conducted to identify relevant studies on PubMed, Scopus, CENTRAL, and through hand searching. Randomized controlled trial design studies performing interventions to improve medication adherence led by pharmacists among patients living with multimorbidity were included. We focused on original search with the key concepts of “multimorbidity”, “pharmacists”, and “medication adherence”. Narrative synthesis was used to extract and synthesize the data. Results: Twelve studies that included participants with multimorbidity were reviewed. Nine of all twelve studies showed improvement of medication adherence in the intervention group with a p-value < 0.05, while three other studies indicated no significant difference between the intervention and control groups. All of the studies employed personalized interventions. Interventions used could be divided into counselling sessions, medication management, or using a supporting tool as a reminder of drug administration. Conclusion: In nine out of twelve studies, interventions led by pharmacists were found to be effective in improving medication adherence in patients with multimorbidity. Effective interventions showed significant improvement in medication adherence in the intervention group compared with the usual care group. These interventions included counselling sessions, medication management, and the use of a supporting tool to remind patients about drug administration.

1 January 2026 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
SASofa Dewi Alfian
Sofa Dewi Alfian
LFLubna Farhana
Lubna Farhana
QKQisty A. Khoiry
Qisty A. Khoiry
SCSusan F. Candradewi
Susan F. Candradewi
Bernard VrijensBernard Vrijens
Bernard Vrijens
RARizky Abdulah
Rizky Abdulah
Medication adherence is a key determinant of glycemic control, and it comprises three interrelated phases, namely, initiation, implementation, and discontinuation, as conceptualized by the ABC taxonomy. Therefore, this umbrella review aims to identify and classify factors influencing medication adherence among patients with diabetes across the three phases. A systematic search was conducted in MEDLINE, EBSCO, and Scopus (inception to May 2025) to identify systematic reviews on factors associated with medication adherence in adults with type 1 or 2 diabetes mellitus. Data were then extracted and mapped to the ABC taxonomy and five conceptual domains. Methodological quality was assessed using AMSTAR 2, and a total of 28 systematic reviews comprising 795 studies were included. The majority of the evidence found focused on implementation, with limited studies examining initiation and discontinuation. The results showed that initiation was primarily influenced by patient‐related factors (e.g., fear of injections, health beliefs, and self‐efficacy) and socioeconomic factors (e.g., income, education, and social support). Meanwhile, implementation was determined by a broader range of factors, including health literacy, regimen complexity, adverse effects, and financial burden. In the discontinuation phase, financial constraints, insurance, treatment efficacy, and adverse effects were the most frequent factors. The current review emphasizes that medication adherence in diabetes is a multifactorial, phase‐dependent process characterized by distinct but overlapping determinants across the adherence continuum. The majority of the reviews were judged to be of moderate to high quality. Future original studies are advised to consistently apply the ABC taxonomy to clearly distinguish adherence phases and to generate phase‐specific evidence that can better inform targeted interventions.